Abstracts
Showing 852 abstracts.
Citation
M Boivin, M Chernoff, B Laughton, B Zimmer, C Joyce, L Barlow-Mosha, M Bwakura-Dangarembizi, M Ratswana, L Fairlie, P Kamthunzi, K McCarthy, P Jean-Philippe, A Violari, M Cotton, P Palumbo. African multi-site 2-year study of neurocognition in HIV infected/affected children. Presented at: CROI 2018; 2018 Mar 06.Conference
CROI 2018
Study
P1104s
Citation
Priyanka Uprety, Kaitlin Rainwater-Lovett, Ellen Chadwick, Edmund Capparelli, Carrie Ziemniak, Katherine Luzuriaga, Larry Moulton, Deborah Persaud. Age of Antiretroviral Treatment on Decay and HIV-1 DNA Reservoir Size during Infancy. Presented at: CROI 2015.Conference
CROI 2015
Study
P1030
Citation
Deborah S. Storm, R.N.,Ph.D, Joan H. Skurnick, Yan He, M.S., Mary D. Boland, R.N., M.S.N, D.P.H., Lois C. Howland, M.S., M.P.H., D.Ph., James M. Oleske, M.D. Age, Symptom Assessment and Reporting in Children and Youth with HIV Infection During 1993-2000. Presented at: Eastern Nursing Research Society 2004.Conference
Eastern Nursing Research Society 2004
Citation
Age-Related Differences in Plasma and Intracellular (IC) Tenofovir (TFV) Concentrations.Citation
Edmund Capparelli, Pharm.D., Brian Robbins, Ph.D., Mobeen H. Rathore, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Adriana Weinberg, M.D., Renee Browning, R.N., M.S.N, Rohan Hazra, M.D., Ross E. McKinney, Jr., M.D., Michael Rochon-Duck. Age-Related Pharmacokinetics of Efavirenz Solution. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1021
Citation
James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Michael T. Brady, M.D. AIDS Clinical Trials Group (ACTG) Protocol 219: A PediatricHIV Late Outcomes Protocol.Citation
Kumud K. Singh, Akihiko Saitoh, M.D., Christine Powell, M.A., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D. Allelic Variants of MDRI Alter Pharmacokinetics of Nelfinavir Resulting in Higher Drug Levels and More Rapid Decline in Plasma HIV-1 RNA in Children.Citation
Grace M. Ahimbisibwe, Yanling Huo, Lisa Aaron, Joseph Szewczyk, Adit Dhummakupt, Damayanti Yengkhom, Aaron A.R. Tobian, Avy Violari, Mark Cotton, Amita Gupta, Adriana Weinberg, Philippa Musoke, Deborah Persaud. An analysis of changes in HIV-1 Proviral DNA in Women with HIV from antepartum through 48 weeks postpartum in the IMPAACT P1078 study. Presented at: International AIDS Conference; 2026 Jul 26; Rio de Janeiro, Brazil.Conference
International AIDS Conference
Study
P1078
Conference Location
Rio de Janeiro, Brazil
Citation
Wayne M. Dankner, M.D., Sharon Appelbaum Nachman, M.D., Michael Hughes, Ph.D., Philimon Gona, Ph.D., Sharon Huang, M.S., Sharon Huang, M.S., Carol Elgie, B.S., Ram Yogev, M.D. An Observational Study of the Rate of Opportunistic Infection (OI) Events In HIV-Infected Children Who Have Demonstrated Immunologic Reconstitution And Who Have Discontinued OI Prophylaxis.Study
P1008